These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8804022)

  • 1. Microglia-derived macrophages in early multiple sclerosis plaques.
    Li H; Cuzner ML; Newcombe J
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):207-15. PubMed ID: 8804022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
    Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
    Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
    van Horssen J; Vos CM; Admiraal L; van Haastert ES; Montagne L; van der Valk P; de Vries HE
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):585-93. PubMed ID: 17083473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains.
    Zhang Z; Zhang ZY; Schittenhelm J; Wu Y; Meyermann R; Schluesener HJ
    J Neuroimmunol; 2011 Aug; 237(1-2):73-9. PubMed ID: 21737148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulins and complement in postmortem multiple sclerosis tissue.
    Barnett MH; Parratt JD; Cho ES; Prineas JW
    Ann Neurol; 2009 Jan; 65(1):32-46. PubMed ID: 19194879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase activity in multiple sclerosis neuropathology.
    Darvesh S; Leblanc AM; Macdonald IR; Reid GA; Bhan V; Macaulay RJ; Fisk JD
    Chem Biol Interact; 2010 Sep; 187(1-3):425-31. PubMed ID: 20122907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.
    Li Y; Chu N; Hu A; Gran B; Rostami A; Zhang GX
    Brain; 2007 Feb; 130(Pt 2):490-501. PubMed ID: 17003070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte/macrophage differentiation in early multiple sclerosis lesions.
    Brück W; Porada P; Poser S; Rieckmann P; Hanefeld F; Kretzschmar HA; Lassmann H
    Ann Neurol; 1995 Nov; 38(5):788-96. PubMed ID: 7486871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytes, lipid-removal and regression of atheroma.
    Adams CW; Bayliss OB; Turner DR
    J Pathol; 1975 Aug; 116(4):225-38. PubMed ID: 811781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis.
    Prineas JW; Wright RG
    Lab Invest; 1978 Apr; 38(4):409-21. PubMed ID: 205724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.
    De Groot CJ; Ruuls SR; Theeuwes JW; Dijkstra CD; Van der Valk P
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):10-20. PubMed ID: 8990125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques.
    Li H; Newcombe J; Groome NP; Cuzner ML
    Neuropathol Appl Neurobiol; 1993 Jun; 19(3):214-23. PubMed ID: 7689189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.
    Metz I; Lucchinetti CF; Openshaw H; Garcia-Merino A; Lassmann H; Freedman MS; Atkins HL; Azzarelli B; Kolar OJ; Brück W
    Brain; 2007 May; 130(Pt 5):1254-62. PubMed ID: 17293360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.